Physician

Morgan Christine Scully, M.D.

According to 2025 Medicare claims, Morgan Scully, M.D. (NPI: 1477996734) practices infectious disease in the Huntsville, AL market, with the plurality of this provider's patient population coming from Madison, AL. This provider's primary affiliated billing organization is METRO INFECTIOUS DISEASE CONSULTANTS, LLC (NPI: 1235125717; TIN: 363966745) and primary practice location at 35801-5029. Scully is affiliated with the American Choice Healthcare, LLC (ACO ID: D0086), participating under the REACH model.

Scully's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 577 traditional Medicare patients, billed 62,619 HCPCS/CPT codes, and received $1,260,348 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 677 prescription claims across 116 beneficiaries totaling $158,231 in drug costs, led by Dalvance (Dalbavancin Hcl). Open Payments data shows 2 records totaling $133. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $244,162 and ending at $1,260,348. Concurrently, Part D prescription costs have fallen sharply in recent years, from $6,187 to $158,231. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	203	10,296	$244,162
2019	556	43,838	$707,815
2020	625	38,140	$1,550,787
2021	573	56,322	$1,464,688
2022	613	58,464	$912,869
2023	495	35,426	$755,830
2024	577	62,619	$1,260,348

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	38	210	$6,187
2016	56	289	$69,479
2017	55	726	$474,551
2018	73	837	$574,743
2019	101	442	$368,246
2020	123	561	$335,004
2021	102	505	$140,323
2022	104	577	$171,608
2023	88	424	$80,426
2024	116	677	$158,231

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	237	260	$122
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	75	129	$87
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	296	1,174	$86
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	74	116	$56
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	98	230	$42

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dalvance	Dalbavancin Hcl	12	72	$31,820
Ertapenem	Ertapenem Sodium	54	313	$25,244
Daptomycin	Daptomycin	44	298	$24,941
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	20	138	$4,091
Methenamine Hippurate	Methenamine Hippurate	35	1,230	$2,558

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$133	ViiV Healthcare Company
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Morgan Christine Scully, M.D.?

Tedicare shows public-source Medicare data for Morgan Christine Scully, M.D. (NPI 1477996734), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Morgan Christine Scully, M.D. have ACO affiliation data?

Morgan Christine Scully, M.D. is shown with ACO affiliation data for American Choice Healthcare, LLC (REACH, ACO ID D0086).

What billing organization is linked to Morgan Christine Scully, M.D.?

Morgan Christine Scully, M.D. is linked to METRO INFECTIOUS DISEASE CONSULTANTS, LLC (billing NPI 1235125717) in the available physician profile data.

Does Morgan Christine Scully, M.D. have Open Payments data?

Morgan Christine Scully, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.